2009-2010年孕妇接种大流行H1N1流感疫苗后的出生结局
研究基于2009-2010年北加州凯撒医疗集团5365名孕妇队列,比较不同免疫组早产、低出生体重、自然流产、死产和先天畸形等不良出生结局的发生率。结果显示各组间无显著差异,H1N1疫苗与TIV疫苗的不良出生结局发生率相似。
要点
- H1N1疫苗与TIV疫苗相比,早产(6.37 vs 6.28/100出生)和低出生体重(4.19 vs 2.90/100出生)等发生率相似。
- 各组间不良出生结局发生率无显著差异。
- 研究受样本量小、疫苗组复杂和2009-2010年疫苗供应差异限制。
核心结论
- 研究未发现H1N1疫苗与TIV疫苗在不良出生结局方面存在差异。
研究设计与样本
- 基于2009-2010年北加州凯撒医疗集团5365名孕妇的队列,通过电话调查评估接种H1N1、TIV或两者后的非就医反应,并比较不同免疫组的不良出生结局发生率及95%置信区间。
主要发现
- H1N1组与TIV组比较:早产发生率6.37 vs 6.28/100出生,极早产5.30 vs 8.29/1000出生,低出生体重4.19 vs 2.90/100出生,极低出生体重4.54 vs 5.52/1000出生,小于胎龄儿9.99 vs 9.24/1000出生,自然流产7.10 vs 6.83/1000妊娠,死产7.10 vs 4.57/1000妊娠,先天畸形2.66 vs 2.43/100出生。
- 各组间结果无显著差异。
局限性
- 样本量小。
- 疫苗组复杂。
- 2009-2010年疫苗供应存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following the H1N1 influenza pandemic in 2009, pregnant women were recommended to receive both seasonal (TIV) and H1N1 influenza vaccines. This study presents incidence of adverse birth and pregnancy outcomes among a population of pregnant women immunized with TIV and H1N1 vaccines at Kaiser Permanente Northern California during 2009-2010. METHODS: We telephone surveyed pregnant Kaiser Permanente Northern California members to assess non-medically-attended reactions following H1N1, TIV or both vaccines during 2009-2010 (n=5365) in a separate study. Here we assessed preterm birth (<37weeks), very preterm birth (<32weeks), low birth weight (<2500 g, LBW), very low birth weight (<1500g), small for gestational age, spontaneous abortions, stillbirths and congenital anomalies among this cohort by comparing incidence and 95% confidence intervals between the following immunization groups: TIV only, H1N1 only, H1N1 prior to TIV immunization, TIV prior to H1N1 and both immunizations given at the same time. RESULTS: Results did not vary significantly between groups. Comparing H1N1 with TIV, incidence were similar for preterm births (6.37vs 6.28/100 births), very preterm births (5.30vs 8.29/1000 births), LBW (4.19vs 2.90/100 births), very LBW (4.54vs 5.52/1000 births), small for gestational age (9.99vs 9.24/1000 births), spontaneous abortion (7.10vs 6.83/1000 pregnancies), stillbirths (7.10vs 4.57/1000 pregnancies), and congenital anomalies (2.66vs 2.43/100 births). CONCLUSIONS: Although constrained by small sample size, complex vaccine groups, and differential vaccine availability during 2009-2010, this study found no difference in adverse birth outcomes between H1N1 vaccine and TIV.
引用
- Eaton A, Lewis N, Fireman B, et al. Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010. Vaccine. 2017. PMID: 28917536. doi:10.1016/j.vaccine.2017.08.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。